AI Science Tracker
EN

Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation study.

Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine; Syracuse University · 31 May 2021 · medicine

Discovery

Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation study.

Source check: Source checked. Not independent scientific confirmation.

Finding: The study trained on 552 resection patients and tested on a 144-patient transplant cohort and 302 TCGA cases; recurrence-free-survival associations were reported. The cohorts are retrospective, the training set used selected outcome groups, and prospective clinical utility was not tested. The first located result-bearing version was arXiv v1 (2021-05-31); the journal version appeared online 2022-03-29. The date is the first located result-bearing preprint; the later peer-reviewed journal version is linked separately.

Technology: A U-Net segmentation heat map was combined with color-normalized histology tiles for a MobileNetV2 classifier estimating hepatocellular-carcinoma recurrence risk.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A U-Net segmentation heat map was combined with color-normalized histology tiles for a MobileNetV2 classifier estimating hepatocellular-carcinoma recurrence risk.
Test and result
The study trained on 552 resection patients and tested on a 144-patient transplant cohort and 302 TCGA cases; recurrence-free-survival associations were reported.
Limitation / still unknown
The cohorts are retrospective, the training set used selected outcome groups, and prospective clinical utility was not tested. The first located result-bearing version was arXiv v1 (2021-05-31); the journal version appeared online 2022-03-29.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://arxiv.org/abs/2106.00090v1 · https://doi.org/10.1007/s12072-022-10321-y

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.